Your browser doesn't support javascript.
loading
Effect of butylscopolamine on image quality in MRI of the prostate.
Wagner, M; Rief, M; Busch, J; Scheurig, C; Taupitz, M; Hamm, B; Franiel, T.
Afiliación
  • Wagner M; Department of Radiology, Charité - Universitätsmedizin Berlin, Germany. moritz.wagner@charite.de
Clin Radiol ; 65(6): 460-4, 2010 Jun.
Article en En | MEDLINE | ID: mdl-20451013
AIM: To evaluate the impact of butylscopolamine on the quality of magnetic resonance imaging (MRI) images of the prostate. MATERIAL AND METHODS: Eighty-two MRI examinations of the prostate were retrospectively analysed. MRI was performed with a combined endorectal/body phased-array coil including proton density-weighted (PD) sequence, T1-weighted turbo spin-echo (TSE)-sequence, and T2-weighted TSE-sequences. Forty milligrams of butylscopolamine was administered intramuscularly in 31 patients (im-group) and intravenously in 30 patients (iv-group). Twenty-one patients did not receive premedication with butylscopolamine (ø-group). Overall image quality, delineation of the bowel wall, and visualization of the prostate, neurovascular bundle, and pelvic lymph nodes were evaluated qualitatively using a five-point scale (from 1=excellent to 5=non-diagnostic/structure not discernible). Motion artefacts within the endorectal coil were quantified by baseline adjusted signal intensities inside the endorectal coil area. RESULTS: Delineation of the bowel wall using the PD-sequence was significantly improved after both intramuscular and intravenous butylscopolamine administration (ø-group: 3.6+/-0.7; im-group: 2.9+/-0.7; iv-group: 2.9+/-0.7; p=0.001). However, there were no significant differences in motion artefacts measured within the endorectal coil (ø-group: 1.18+/-0.14; im-group: 1.15+/-0.11; iv-group: 1.12+/-0.06; p=0.39). There were also no significant differences in qualitative assessment of visualization of the prostate, neurovascular bundle, pelvic lymph nodes, and of overall image quality between the study groups. CONCLUSION: : In conclusion, butylscopolamine had only a small effect on image quality and is not mandatory for MRI of the prostate.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Bromuro de Butilescopolamonio / Imagen por Resonancia Magnética / Aumento de la Imagen / Antagonistas Muscarínicos Tipo de estudio: Diagnostic_studies / Evaluation_studies / Observational_studies / Qualitative_research Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Clin Radiol Año: 2010 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Bromuro de Butilescopolamonio / Imagen por Resonancia Magnética / Aumento de la Imagen / Antagonistas Muscarínicos Tipo de estudio: Diagnostic_studies / Evaluation_studies / Observational_studies / Qualitative_research Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Clin Radiol Año: 2010 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido